Original Study| Volume 21, ISSUE 1, P91-104, February 2023

Download started.


Prognostic Role of Long-Chain Acyl-Coenzyme A Synthetase Family Genes in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Bioinformatics Analysis Confirmed with External Validation Cohorts

Published:November 22, 2022DOI:



      We aimed to determine the prognostic role of long-chain acyl-CoA synthetases (ACSLs) as a disease marker for kidney clear cell carcinoma (KIRC).

      Patients and Methods

      The Cancer Genome Atlas (TCGA) data were accessed via open access LinkedOmics database for KIRC. Provisional datasets were used for analysis as previously described and gene expression quantification data were downloaded. The corresponding clinical information of patients also were obtained from the database. Five ACSL family members, ACSL1, ACSL3, ACSL4, ACSL5, and ACSL6, were investigated in the TCGA-KIRC cohort. Xena browser, cBioPortal and UALCAN, and Cancer Cell Line Encyclopedia (CCLE) databases were also used to confirm the results. External validation was performed using patient cohorts from the Gene Expression Omnibus (GEO-NCBI) database. Finally, the protein–protein interaction (PPI) was constructed based on the Search Tool for the Retrieval of Interacting Genes (STRING) database and visualized using Cytoscape software.


      Pathological T3-T4 stage tumors had significantly lower ACSL1 mRNA expression (P = .009). Patients with pathologically confirmed metastasis exhibited significantly lower expression, as well (P = .02). ACSL1 mRNA expression was associated with overall survival (OS) and negatively correlated with OS time. Univariate and multivariate analyses showed that lower ACSL1 mRNA expression level was associated with mortality. Moreover, ACSL1 mRNA expression was exhibited significant difference in some VHL gene region mutations and PBRM1_p.R1010 mutation, and negatively correlated with HIF1-alpha mRNA expression (P < .001). Confirmatory analyses and external validation also revealed similar findings.


      Lowered ACSL1 mRNA expression is associated with worse tumor histopathology and poor overall survival in KIRC. It may be used for prognostic marker for KIRC.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Genitourinary Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hsieh JJ
        • Purdue MP
        • Signoretti S
        • et al.
        Renal cell carcinoma.
        Nat Rev Dis Primers. 2017; 3 (PMID: 28276433; PMCID: PMC5936048): 17009
        • Li X
        • Turanli B
        • Juszczak K
        • et al.
        Classification of clear cell renal cell carcinoma based on PKM alternative splicing.
        Heliyon. 2020; 6: e03440
        • Andreiana BC
        • Stepan AE
        • Margaritescu C
        • et al.
        Histopathological Prognostic Factors in Clear Cell Renal Cell Carcinoma.
        Curr Health Sci J. 2018; 44: 201-205
        • Du W
        • Zhang L
        • Brett-Morris A
        • et al.
        HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism.
        Nat Commun. 2017; 8: 1769
        • Goldman MJ
        • Craft B
        • Hastie M
        • et al.
        Visualizing and interpreting cancer genomics data via the Xena platform.
        Nat Biotechnol. 2020; 38: 675-678
        • Vasaikar SV
        • Straub P
        • Wang J
        • Zhang B.
        LinkedOmics: analyzing multi-omics data within and across 32 cancer types.
        Nucleic Acids Res. 2018; 46: D956-DD63
        • Gao J
        • Aksoy BA
        • Dogrusoz U
        • et al.
        Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
        Sci Signal. 2013; 6: pl1
        • Clough E
        • Barrett T.
        The Gene Expression Omnibus Database.
        Methods Mol Biol. 2016; 1418: 93-110
        • Chandrashekar DS
        • Karthikeyan SK
        • Korla PK
        • et al.
        UALCAN: An update to the integrated cancer data analysis platform.
        Neoplasia. 2022; 25: 18-27
        • Barretina J
        • Caponigro G
        • Stransky N
        • et al.
        The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity.
        Nature. 2012; 483: 603-607
        • Szklarczyk D
        • Franceschini A
        • Wyder S
        • et al.
        STRING v10: protein-protein interaction networks, integrated over the tree of life.
        Nucleic Acids Res. 2015; 43: D447-D452
        • Shannon P
        • Markiel A
        • Ozier O
        • et al.
        Cytoscape: a software environment for integrated models of biomolecular interaction networks.
        Genome Res. 2003; 13: 2498-2504
        • Saito R
        • Smoot ME
        • Ono K
        • et al.
        A travel guide to Cytoscape plugins.
        Nat Methods. 2012; 9: 1069-1076
        • Hao Y
        • Li D
        • Xu Y
        • et al.
        Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
        BMC Bioinformatics. 2019; 20: 195
        • Tang Y
        • Zhou J
        • Hooi SC
        • Jiang YM
        • Lu GD.
        Fatty acid activation in carcinogenesis and cancer development: Essential roles of long-chain acyl-CoA synthetases.
        Oncol Lett. 2018; 16: 1390-1396
        • Bobulescu IA
        • Pop LM
        • Mani C
        • et al.
        Renal Lipid Metabolism abnormalities in Obesity and Clear Cell Renal Cell Carcinoma.
        Metabolites. 2021; : 11
        • Chen WC
        • Wang CY
        • Hung YH
        • Weng TY
        • Yen MC
        • Lai MD.
        Systematic Analysis of Gene Expression alterations and clinical outcomes for Long-Chain Acyl-Coenzyme A Synthetase family in Cancer.
        PLoS One. 2016; 11e0155660
        • Sanchez-Martinez R
        • Cruz-Gil S
        • Garcia-Alvarez MS
        • Reglero G
        • Ramirez de Molina A
        Complementary ACSL isoforms contribute to a non-Warburg advantageous energetic status characterizing invasive colon cancer cells.
        Sci Rep. 2017; 7: 11143
        • Sanchez-Martinez R
        • Cruz-Gil S
        • Gomez de Cedron
        • et al.
        A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy.
        Oncotarget. 2015; 6: 38719-38736
        • Wang Y
        • Cai X
        • Zhang S
        • et al.
        HBXIP up-regulates ACSL1 through activating transcriptional factor Sp1 in breast cancer.
        Biochem Biophys Res Commun. 2017; 484: 565-571
        • Cui M
        • Wang Y
        • Sun B
        • Xiao Z
        • Ye L
        • Zhang X.
        MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.
        Biochem Biophys Res Commun. 2014; 444: 270-275
        • Cui M
        • Xiao Z
        • Wang Y
        • et al.
        Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway.
        Cancer Res. 2015; 75: 846-857
        • Ivyna Bong PN
        • Ng CC
        • Lam KY
        • Megat Baharuddin PJ
        • Chang KM
        • Zakaria Z
        Identification of novel pathogenic copy number aberrations in multiple myeloma: the Malaysian context.
        Mol Cytogenet. 2014; 7: 24
        • Huang W
        • Jin Y
        • Yuan Y
        • et al.
        Validation and target gene screening of hsa-miR-205 in lung squamous cell carcinoma.
        Chin Med J (Engl). 2014; 127: 228-272
        • Vargas T
        • Moreno-Rubio J
        • Herranz J
        • et al.
        3′UTR Polymorphism in ACSL1 Gene correlates with Expression levels and poor clinical outcome in Colon Cancer patients.
        PLoS One. 2016; 11e0168423
      1. The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma.
        Nature. 2013; 499: 43-49
        • Sato Y
        • Yoshizato T
        • Shiraishi Y
        • Maekawa S
        • Okuno Y
        • Kamura T
        • et al.
        Integrated molecular analysis of clear-cell renal cell carcinoma.
        Nat Genet. 2013; 45: 860-867
        • Shen C
        • Kaelin Jr, WG
        The VHL/HIF axis in clear cell renal carcinoma.
        Semin Cancer Biol. 2013; 23: 18-25
        • Nargund AM
        • Pham CG
        • Dong Y
        • et al.
        The SWI/SNF Protein PBRM1 Restrains VHL-loss-driven clear Cell Renal Cell Carcinoma.
        Cell Rep. 2017; 18: 2893-2906
        • Gao W
        • Li W
        • Xiao T
        • Liu XS
        • Kaelin Jr, WG
        Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL-/- clear cell renal carcinoma.
        Proc Natl Acad Sci U S A. 2017; 114: 1027-1032
        • Hoefflin R
        • Harlander S
        • Schafer S
        • et al.
        HIF-1alpha and HIF-2alpha differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice.
        Nat Commun. 2020; 11: 4111
        • Kim YS
        • Jung J
        • Jeong H
        • et al.
        High Membranous Expression of Fatty Acid Transport Protein 4 Is associated with Tumorigenesis and Tumor Progression in Clear Cell Renal Cell Carcinoma.
        Dis Markers. 2019; 20195702026